Secor Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Secor Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-31,661	Closed	-$1.5M	–	48
2019 Q1	$1.5M	Buy	+31,661	New	+$1.58M	0.31%	100
2018 Q2	–	Sell	-47,383	Closed	-$2.98M	–	505
2018 Q1	$2.98M	Buy	+47,383	New	+$3.05M	0.24%	134
2017 Q3	–	Sell	-54,889	Closed	-$3.06M	–	439
2017 Q2	$3.06M	Buy	+54,889	New	+$2.99M	0.28%	117
2017 Q1	–	Sell	-6,741	Closed	-$370K	–	462
2016 Q4	$394K	Sell	6,741 -1,282	-16%	-$70.1K	0.05%	378
2016 Q3	$433K	Sell	8,023 -2,839	-26%	-$182K	0.05%	385
2016 Q2	$799K	Sell	10,862 -3,714	-25%	-$262K	0.1%	284
2016 Q1	$931K	Buy	+14,576	New	+$919K	0.13%	177
2015 Q4	–	Sell	-4,048	Closed	-$240K	–	538
2015 Q3	$240K	Sell	4,048 -7,659	-65%	-$486K	0.08%	405
2015 Q2	$779K	Sell	11,707 -3,921	-25%	-$258K	0.28%	124
2015 Q1	$1.01M	Buy	+15,628	New	+$978K	0.39%	56
2014 Q2	–	Sell	-10,465	Closed	-$544K	–	240
2014 Q1	$544K	Buy	+10,465	New	+$557K	0.27%	135

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Secor Capital Advisors's BMY Position: Q2 2019 in Review

Secor Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 31,661 shares — an estimated $1.5M sold.

Secor Capital Advisors first reported a position in BMY in Q1 2014 and held it in 11 quarters. The position peaked at $3.06M in Q2 2017. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Secor Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Secor Capital Advisors sold 31,661 Bristol-Myers Squibb shares in Q2 2019, an estimated $1.5M.
Secor Capital Advisors first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 11 quarters.
Secor Capital Advisors's Bristol-Myers Squibb position peaked at $3.06M in Q2 2017.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.